Plans for the US Cancer Moonshot became a little clearer yesterday, when the Blue Ribbon Panel of expert advisers issued a set of 10 recommendations for cancer research.
The Cancer Moonshot, headed by Vice-President Joe Biden, aims to make 10 years' worth of progress in cancer research within the next 5 years.
How to do just that is now outlined in the Blue Ribbon Panel report.
The panel's recommendations have been presented to the National Cancer Advisory Board, the advisor to the National Cancer Institute (NCI). However, how much of the research recommended by the panel will actually be carried out depends on how much funding is approved by Congress
"This is an enormous, once-in-a-lifetime opportunity for the cancer community and our nation to come together around a single disease that touches everyone," co-chairs of the Blue Ribbon Panel write in an introduction to the report.
This report identifies "a finite set of programs that are poised for acceleration and that could unleash new cancer breakthroughs if implemented," they write.
The three cochairs are Tyler Jacks, PhD, director, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Boston; Elizabeth Jaffee, MD, professor and deputy director for translational research, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland; and Dinah Singer, PhD, acting deputy director, National Cancer Institute, and director, Division of Cancer Biology, NCI, Bethesda, Maryland. The 28 members of the panel include cancer researchers, oncologists, patient advocates, and representatives from the private sector and government agencies.
The 10 Recommendations
The new recommendations for cancer research are outlined in an NCI document that also features videos showing panel members elaborating on the plans. The 10 points are summarized below:
Cancer societies were quick to respond with praise for the report. The American Association for Cancer Research said it "embraces" the new plan, and the American Society of Clinical Oncology (ASCO) said it "applauds" what it describes as bold and ambitious recommendations.
"The recommendations could significantly expedite our nation's progress against cancer if implemented," ASCO President Daniel F. Hayes, MD, said in a statement. "For this to happen, it is crucial that Congress provide the necessary funding."
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου